A detailed history of Crewe Advisors LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Crewe Advisors LLC holds 911 shares of ZTS stock, worth $159,388. This represents 0.02% of its overall portfolio holdings.

Number of Shares
911
Holding current value
$159,388
% of portfolio
0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$165.67 - $199.94 $150,925 - $182,145
911 New
911 $154,000
Q2 2023

Jul 28, 2023

SELL
$160.94 - $186.23 $20,600 - $23,837
-128 Reduced 13.91%
792 $136,000
Q1 2023

May 12, 2023

SELL
$145.48 - $175.02 $1,454 - $1,750
-10 Reduced 1.08%
920 $153,000
Q4 2022

Feb 07, 2023

SELL
$131.14 - $157.47 $32,785 - $39,367
-250 Reduced 21.19%
930 $136,000
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $9,935 - $12,230
67 Added 6.02%
1,180 $175,000
Q2 2022

Aug 02, 2022

BUY
$155.97 - $200.09 $143,024 - $183,482
917 Added 467.86%
1,113 $191,000
Q4 2021

Feb 10, 2022

SELL
$193.69 - $247.03 $4,067 - $5,187
-21 Reduced 9.68%
196 $48,000
Q3 2021

Oct 29, 2021

SELL
$189.29 - $209.69 $2,082 - $2,306
-11 Reduced 4.82%
217 $42,000
Q2 2021

Aug 11, 2021

SELL
$155.9 - $187.99 $2,962 - $3,571
-19 Reduced 7.69%
228 $42,000
Q1 2021

Apr 21, 2021

BUY
$144.0 - $169.39 $1,872 - $2,202
13 Added 5.56%
247 $39,000
Q4 2020

Jan 27, 2021

BUY
$157.07 - $174.35 $3,926 - $4,358
25 Added 11.96%
234 $39,000
Q3 2020

Oct 13, 2020

BUY
$137.1 - $165.37 $24,129 - $29,105
176 Added 533.33%
209 $35,000
Q2 2020

Jul 24, 2020

BUY
$111.92 - $142.53 $3,693 - $4,703
33 New
33 $5,000
Q4 2019

Feb 05, 2020

SELL
$116.25 - $133.25 $88,931 - $101,936
-765 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$97.98 - $114.28 $7,544 - $8,799
77 Added 11.19%
765 $87,000
Q1 2019

May 10, 2019

BUY
$81.56 - $100.67 $56,113 - $69,260
688 New
688 $69,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.